Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05941013 · ClinicalTrials.gov registry record · NA
Ultrasound-detectable Endotracheal Tube: a Feasibility Study
A NA study of Cardiac Catheterization and Endotracheal Tube, sponsored by John R. Charpie.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05941013: Recruiting NA study of Cardiac Catheterization and Endotracheal Tube, sponsored by John R. Charpie.
NCT05941013 is a NA study of Cardiac Catheterization and Endotracheal Tube that is actively recruiting participants, run by John R. Charpie. The registered enrollment target is 20 participants, below the 229-participant average among 6 other Cardiac Catheterization trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05941013, a NA study of Cardiac Catheterization and Endotracheal Tube, is actively recruiting participants, sponsored by John R. Charpie.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers are studying whether special features make it easier to see if the breathing tube is in the correct place. It is hoped that the investigational device will enable more accurate placement (depth and trachea vs. esophagus).
Primary Outcome
Reported as a 'yes' or 'no' - this outcome simply seeks to verify if the ultrasound can detect the ultrasound detectable cuffed endotracheal tube. The outcome measure assesses if the device is detectable as designed. It does not assess health related information.
Conditions Studied
Interventions
- DEVICE Ultrasound detectable cuffed endotracheal tube (USD-ETT)
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT05941013 shows while recruiting
NCT05941013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 229-participant average among 6 other Cardiac Catheterization trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Cardiac Catheterization appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound detectable cuffed endotracheal tube (USD-ETT) is the first listed.
NCT05941013 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05941013 about?
NCT05941013 is a clinical study titled "Ultrasound-detectable Endotracheal Tube: a Feasibility Study". The researchers are studying whether special features make it easier to see if the breathing tube is in the correct place. It is hoped that the investigational device will enable more accurate placement (depth and trachea vs. esophagus).
What is the current status of trial NCT05941013?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-11-15. Estimated completion is 2027-04.
What conditions does trial NCT05941013 study?
This clinical trial studies the following conditions: Cardiac Catheterization, Endotracheal Tube.
What interventions are being tested in trial NCT05941013?
The interventions under investigation include: Ultrasound detectable cuffed endotracheal tube (USD-ETT) (DEVICE).
Who is sponsoring clinical trial NCT05941013?
This trial is sponsored by John R. Charpie, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05941013 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Catheterization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Anesthesia Care Unit (PACU) Weighted Blanket Study
COMPLETED · NA
-
Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
COMPLETED · NA
-
Femoral Arterial Access With Ultrasound Trial
COMPLETED · NA
-
Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
COMPLETED · NA
-
GSI Cardiac on Revolution Apex - US
RECRUITING
-
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI